CRISPRMED24 Testimonial - Pietro De Angeli PhD
By: WeDoCRISPR - Nov. 24, 2024
Pietro De Angeli PhD is a Project Lead Scientist in Professor Bernd Wissinger’s team at the Institute for Ophthalmic Research, Tübingen University Hospital, Germany. Here, he is involved in pre-clinical gene-editing research for inherited retinal disorders. Hear what he has to say anout CRISPRMED24!
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Recurrent or Progressive High-grade Glioma, (NCT06737146)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors, (NCT06912152)
Sponsors:
Zhejiang University
Sponsors:
Zhejiang University
IND Enabling
Phase I
Phase II
Phase III